AVEXIS technology identifies novel platelet-leukocyte binding partners including CD148-CD300a

Blood Adv. 2021 Dec 14;5(23):5016-5019. doi: 10.1182/bloodadvances.2021004546.

Authors

Ruben Barroso^{1

2}, Roy Bicknell^{1

2}, George Ed Rainger¹, Steve P Watson^{1

2}, Yi Sun^{1

2}

Affiliations

¹ Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK; and.
² Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, The Midlands, Birmingham, UK.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Blood Platelets*
Leukocytes*
Phagocytosis
Technology

Grants and funding